Home > Food & Beverages > Nutraceuticals > Protein Supplements > Proanthocyanidins Market
Proanthocyanidins Market size was valued at USD 10.2 billion in 2023 and is projected to grow at 5.1% CAGR from 2024 to 2032. Proanthocyanidins, naturally occurring polyphenols, are found in various plant-based foods, including chocolate, red wine, apples, and cacao beans. Renowned for their potent antioxidant properties, these compounds effectively combat oxidative stress.
Composed of monomers such as epicatechin, catechin, epigallocatechin, and gallocatechin, proanthocyanidins are often called condensed tannins or procyanidins. These plant pigments are responsible for imparting blue, purple, or red hues to flowers and fruits. According to the USDA, the average intake of proanthocyanidins in the American diet is approximately 53.6 mg per day.
Concentrated primarily in the outer skin of seeds and tree barks, proanthocyanidins play a crucial role in plant growth, coloration, and developing an astringent taste to deter herbivores. Major extraction methods from plant tissues include liquid/liquid extraction using polar solvents, as well as mechanical, enzyme, microwave, and ultrasound seed treatments. Notably, the efficiency of liquid/liquid extraction for proanthocyanidins increases with the number of hydroxyl groups in their molecular structure. The National Institutes of Health (NIH) reports that proanthocyanidins contribute to a 20% reduction in oxidative stress markers in clinical studies.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Proanthocyanidins Market Size in 2023: | USD 10.2 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 5.1% |
2024 – 2032 Value Projection: | USD 16.1 Billion |
Historical Data for: | 2021-2023 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 172 |
Segments covered: | By Source, By Type, By Application |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Proanthocyanidins, known for their heart and vascular benefits, are poised to drive the growth of the procyanidins market. Their antioxidant activity surpasses that of vitamin C, aiding in the maintenance of healthy blood pressure. Beyond this, proanthocyanidins showcase antitumor, antiproliferative, and anti-inflammatory properties, positioning them as prime candidates for cancer treatment and prevention. Furthermore, their cholesterol-lowering capabilities, ulcer prevention, and protective effects on the digestive and urinary systems bolster their demand as pharmaceutical agents.
The proanthocyanidins industry is experiencing robust growth, driven by increasing consumer awareness of the health benefits associated with these powerful antioxidants, particularly in cardiovascular health, anti-aging, and cancer prevention. The demand is fueled by the rising trend of incorporating natural and plant-based ingredients into dietary supplements, functional foods, and beverages.
Additionally, the cosmetics industry is leveraging proanthocyanidins for their anti-inflammatory and skin-protective properties. The market is also benefiting from ongoing research and development activities aimed at enhancing the bioavailability and efficacy of proanthocyanidins, coupled with a growing preference for organic and non-GMO products. The Asia-Pacific region, particularly China and India, is emerging as a significant market due to increasing disposable income and a growing interest in preventive healthcare.
The pine bark extract segment is projected to capture USD 5.2 billion in 2023 and exhibit a 5% CAGR by 2032. This strong growth is attributed to several key factors, including the rising awareness of pine bark extract's potent antioxidant properties, which are highly valued for supporting cardiovascular health, enhancing skin elasticity, and improving cognitive function. Additionally, the increasing demand for natural and plant-based ingredients in the nutraceutical and functional food sectors is driving the adoption of pine bark extract.
The growing trend towards preventive healthcare, coupled with the expansion of the dietary supplement industry, is further bolstering market growth. Moreover, ongoing research validating the efficacy of pine bark extract in managing chronic conditions and promoting overall well-being is likely to sustain and amplify this upward trajectory.
The proanthocyanidins market from type B segment will expand to USD 6.8 billion in 2024 and garner a 4.9% CAGR from 2024 to 2032. This growth is driven by increasing demand for type B proanthocyanidins, known for their potent antioxidant and anti-inflammatory properties, which are widely utilized in the pharmaceutical, nutraceutical, and cosmetic industries.
The segment's expansion is further supported by rising consumer awareness of the health benefits associated with type B proanthocyanidins, such as improved cardiovascular health, enhanced skin protection, and potential anti-cancer properties. Additionally, the growing interest in plant-based and natural ingredients in various end-use sectors is fueling the demand for type B proanthocyanidins, positioning this segment for steady growth in the coming years.
The Asia Pacific proanthocyanidins market is poised for remarkable growth, with a projected market value of USD 1.6 billion in 2023 and an anticipated compound annual growth rate (CAGR) of 5.4% from 2024 to 2032. This strong growth is driven by increasing consumer awareness of the health benefits associated with proanthocyanidins, particularly in countries like China, Japan, and India, where the focus on preventive healthcare and natural remedies is rising.
Additionally, the expansion of the nutraceutical and functional food industries, along with the growing demand for plant-based ingredients, is fueling market growth. The region's rapidly increasing middle-class population, coupled with higher disposable incomes and greater access to health information, is also contributing to the burgeoning demand for proanthocyanidins in dietary supplements, cosmetics, and pharmaceuticals across Asia Pacific.
In the proanthocyanidins industry, key players such as NOW Foods, Bio-Botanica, and Xian Yuensun Biological Technology are at the forefront of driving market growth through their extensive portfolios of natural and plant-based ingredients. NOW Foods, a prominent player in the nutraceuticals sector, is recognized for its high-quality dietary supplements, including those enriched with proanthocyanidins, which cater to the growing consumer demand for natural health products.
Bio-Botanica and Xian Yuensun Biological Technology are leveraging their expertise in botanical extracts to offer a wide range of proanthocyanidin-rich products, supported by robust research and development efforts to enhance product efficacy and bioavailability. These companies are focused on expanding their product lines and increasing their market presence through strategic partnerships and innovations in extraction technologies.
Other significant players such as Grap’Sud, Advanced Functional Nutrition, and Polyphenolics contribute to the market with specialized proanthocyanidin formulations targeted at specific health benefits, including cardiovascular health, skin protection, and cognitive function. Companies like Swanson and Nexira are capitalizing on the rising trend towards preventive healthcare by offering high-purity proanthocyanidin products that appeal to health-conscious consumers.
Meanwhile, Indena, Activ'Inside, and Naturex are leading the charge in the European market, utilizing their extensive knowledge of polyphenol chemistry to develop cutting-edge proanthocyanidin products that meet the stringent quality standards of the pharmaceutical and cosmetic industries. These companies are continuously investing in research to validate the health benefits of proanthocyanidins, thus driving consumer trust and expanding their global market share.
Top companies operating in the proanthocyanidins industry include:
Click here to Buy Section of this Report
Market, By Source
Market, By Type
Market, By Application
The above information is provided for the following regions and countries: